A0009K0 Share Price Performance
₩0
-44000.00 (-100.00%)
Price ₩0
Share Pricen/a
No recently updated narratives available.
Aimed Bio Inc. develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases. Its multidisciplinary platform offers antibody-drug conjugates, blood-brain barrier penetration, brain immune modulation, and patient-derived models (PDC/PDX). Aimed Bio Inc. was founded in 2018 and is based in Seoul, South Korea.